scholarly journals Construction and Validation of a Potent Epigenetic Modification-Related Prognostic Signature for Osteosarcoma Patients

2021 ◽  
Vol 2021 ◽  
pp. 1-14
Author(s):  
Siyu Liu ◽  
Bing Wu ◽  
Xiaomin Li ◽  
Lulu Zhao ◽  
Wen Wu ◽  
...  

Background. Increasing evidence has shown that tumorigenesis correlates with aberrant epigenetic factors, such as DNA methylation, histone modification, RNA m6A modification, RNA binding proteins, and transcription factors. However, it is unclear that how epigenetic genes linked with alteration contribute to osteosarcoma’s incidence and clinical prognosis. We developed an epigenetic modification-related prognostic model that may improve the diagnosis and prognosis of osteosarcoma. Methods. We investigated the epigenetic modification-associated genes and their clinical significance in osteosarcoma in this research. Our gene transcriptome data were obtained from the TARGET database and the GEO database. Bioinformatics techniques were used to investigate their functionalities. The diagnostic and prognostic models were constructed using univariate and multivariate Cox regression. In addition, we developed a nomogram indicating the practicability of the prognostic model described above. Results. A risk score model constructed based on four epigenetic modification-related genes (MYC, TERT, EIF4E3, and RBM34) can effectively predict the prognosis of patients with osteosarcoma. Based on the risk score and clinical features, we constructed a nomogram. Conclusion. Epigenetic modification-related genes have been identified as important prognostic markers that may assist in osteosarcoma therapy therapeutic decision-making.

2021 ◽  
Author(s):  
Diguang Wen ◽  
Sheng Qiu ◽  
Zuojin Liu

Abstract Background: Increasing evidence has indicated that abnormal epigenetic modification such as RNAm6a modification, histone modification, DNA methylation modification, RNA binding proteins and transcription factors, is correlated with Hepatocarcinogenesis. However, it is unknown how epigenetic modification associated genes contribute to the occurrence and clinical outcome of hepatocellular carcinoma (HCC). Thus, we constructed epigenetic modification associated model that may enhance the diagnosis and prognosis of HCC.METHODS: In this study, we focused on the clinical values of epigenetic modification associated genes for HCC. Our gene expression data were collected from TCGA and a HCC datasets from GEO dataset in order to ensure the reliability of data. Their function was analyzed by bioinformatics methods. We used lasso regression, SUV, logistic regression and cox regression to construct the diagnosis and prognosis models. We also constructed a nomogram for the practicability of the above-mentioned prognosis model. The above results have been verified in an independent liver cancer dataset from ICGC database. Furthermore, we carried out pan cancer analysis to verify the specificity of the above model.RESULT: A large number of epigenetic modification associated genes were significantly different in HCC and normal liver tissues. The gene signatures showed good performance for predicting the occurrence and survival of HCC patients verified by DCA and ROC curve.CONCLUSION: Gene signatures based on epigenetic modification associated genes can be used to identify the occurrence and prognosis of liver cancer.


PLoS ONE ◽  
2021 ◽  
Vol 16 (12) ◽  
pp. e0260876
Author(s):  
Jun Yang ◽  
Jiaying Zhou ◽  
Cuili Li ◽  
Shaohua Wang

Background Neuroblastoma (NB) is the most common solid tumor in children. NB treatment has made significant progress; however, given the high degree of heterogeneity, basic research findings and their clinical application to NB still face challenges. Herein, we identify novel prognostic models for NB. Methods We obtained RNA expression data of NB and normal nervous tissue from TARGET and GTEx databases and determined the differential expression patterns of RNA binding protein (RBP) genes between normal and cancerous tissues. Lasso regression and Cox regression analyses identified the five most important differentially expressed genes and were used to construct a new prognostic model. The function and prognostic value of these RBPs were systematically studied and the predictive accuracy verified in an independent dataset. Results In total, 348 differentially expressed RBPs were identified. Of these, 166 were up-regulated and 182 down-regulated RBPs. Two hubs RBPs (CPEB3 and CTU1) were identified as prognostic-related genes and were chosen to build the prognostic risk score models. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analysis using proportional hazards regression model. A five gene prognostic model: Risk score = (-0.60901*expCPEB3)+(0.851637*expCTU1) was built. Based on this model, the overall survival of patients in the high-risk subgroup was lower (P = 2.152e-04). The area under the curve (AUC) of the receiver-operator characteristic curve of the prognostic model was 0.720 in the TARGET cohort. There were significant differences in the survival rate of patients in the high and low-risk subgroups in the validation data set GSE85047 (P = 0.1237e-08), with the AUC 0.730. The risk model was also regarded as an independent predictor of prognosis (HR = 1.535, 95% CI = 1.368–1.722, P = 2.69E-13). Conclusions This study identified a potential risk model for prognosis in NB using Cox regression analysis. RNA binding proteins (CPEB3 and CTU1) can be used as molecular markers of NB.


2021 ◽  
Vol 11 ◽  
Author(s):  
Yingjuan Lu ◽  
Yongcong Yan ◽  
Bowen Li ◽  
Mo Liu ◽  
Yancan Liang ◽  
...  

PurposeThe biological roles and clinical significance of RNA-binding proteins (RBPs) in oral squamous cell carcinoma (OSCC) are not fully understood. We investigated the prognostic value of RBPs in OSCC using several bioinformatic strategies.Materials and MethodsOSCC data were obtained from a public online database, the Limma R package was used to identify differentially expressed RBPs, and functional enrichment analysis was performed to elucidate the biological functions of the above RBPs in OSCC. We performed protein-protein interaction (PPI) network and Cox regression analyses to extract prognosis-related hub RBPs. Next, we established and validated a prognostic model based on the hub RBPs using Cox regression and risk score analyses.ResultsWe found that the differentially expressed RBPs were closely related to the defense response to viruses and multiple RNA processes. We identified 10 prognosis-related hub RBPs (ZC3H12D, OAS2, INTS10, ACO1, PCBP4, RNASE3, PTGES3L-AARSD1, RNASE13, DDX4, and PCF11) and effectively predicted the overall survival of OSCC patients. The area under the receiver operating characteristic (ROC) curve (AUC) of the risk score model was 0.781, suggesting that our model exhibited excellent prognostic performance. Finally, we built a nomogram integrating the 10 RBPs. The internal validation cohort results showed a reliable predictive capability of the nomogram for OSCC.ConclusionWe established a novel 10-RBP-based model for OSCC that could enable precise individual treatment and follow-up management strategies in the future.


2020 ◽  
Author(s):  
Ming Liu ◽  
Jiayi Xie ◽  
Xiaobei Luo ◽  
Yaxin Luo ◽  
Side Liu ◽  
...  

Abstract Background: Gastric cancer (GC) is one of the most prevalent malignant cancers around the world. Given that abnormal RNA binding proteins (RBPs) are involved in the tumorigenesis, we aimed to explore the potential value of RBPs-associated genes in gastric cancer.Methods: RNA-seq and clinical data were retrieved from The Cancer Genome Atlas (TCGA) database and differentially expressed RBPs genes were screened. GO and KEGG pathway enrichment analyses were implemented to elucidate the roles of RBPs in GC. The protein-protein interaction (PPI) networks of RBPs were carried out, and the hub genes were determined by MCODE built in Cytoscape. The TCGA-STAD dataset was randomly divided into training and testing groups. A prognostic signature including five RBPs was developed within the training cohort after Cox regression and Lasso regression analyses. We used Kaplan–Meier (KM) and receiver operating characteristic (ROC) curves to evaluate the capacity of the model in both groups. Then, a nomogram based on hub RBPs expression was established. Gene Set Enrichment Analysis was performed between the high-risk and low-risk group.Results: A total of 166 up-regulated RBPs and 130 down-regulated RBPs were identified. Via Cox regression and Lasso regression analysis within the training group, five hub RBPs (RNASE1, SETD7, BOLL, PPARGC1B, MSI2) were screened and the prognostic model was constructed. The risk score was calculated and gastric cancer patients were divided into high-risk and low-risk groups. In multivariate analysis, risk score was still an independent prognostic indicator (HR = 1.80, 95% CI = 1.45-2.22, P < 0.01). Patients with low risk had favorable survival rate in both training and testing group compared to those at high risk (P < 0.001). The areas under the ROC curves (AUC) of the prognostic model are 0.718 in the training cohort and 0.651 in the testing cohort. The hub RBPs-based nomogram model exhibited excellent ability to predict the OS of GC. GSEA illustrated that several cancer-related signaling pathways were enriched in patients with a high-risk score.Conclusions: This study discovered a five RBPs signature which might provide a potential prognostic value to GC patients.


2020 ◽  
Author(s):  
Yingjuan Lu ◽  
Yongcong Yan ◽  
Mo Liu ◽  
Yancan Liang ◽  
Yushan Ye ◽  
...  

Abstract Background: The biological roles and clinical significance of RNA-binding proteins (RBPs) in oral squamous cell carcinoma (OSCC) are not fully understood. We investigated the prognostic value of RBPs in OSCC by several bioinformatic strategies.Methods: OSCC data were obtained from a public online database, the Limma R package was used to identify differentially expressed RBPs, and functional enrichment analysis was performed to elucidate the biological functions of the above RBPs in OSCC. We performed protein-protein interaction (PPI) network and Cox regression analyses to extract prognosis-related hub RBPs. Next, we established and validated a prognostic model based on the hub RBPs by Cox regression and risk score analyses.Results: We found that the differentially expressed RBPs were closely related to the defence response to virus and multiple RNA processes. We obtained ten prognosis-related hub RBPs (ZC3H12D, OAS2, INTS10, ACO1, PCBP4, RNASE3, PTGES3L-AARSD1, RNASE13, DDX4, and PCF11) and effectively predicted the overall survival of OSCC patients. The area under the ROC curve (AUC) of the risk score model was 0.781, suggesting that our model had good prognostic performance. Finally, we built a nomogram integrating the ten RBPs. The internal validation cohort results showed a reliable predictive capability of the nomogram for OSCC.Conclusions: We established a novel ten-RBP-based model for OSCC that could enable precise therapeutic targets in the future.


2021 ◽  
Author(s):  
Yukun Jia ◽  
Zhan Peng ◽  
Guangye Wang

Abstract Background: RNA binding proteins (RBP) plays an important role in post-transcriptional regulation. Although the dysregulation of RBP expression is closely related to the occurrence and metastasis of a variety of tumors, there are few reports on RBP in endometrial carcinoma (UCEC). This study aims to establish a RBP-related prognostic model of UCEC. Methods: We downloaded UCEC gene expression and clinical information data from the Cancer Genome Atlas (TCGA) and GEO database, and determined RBPs that are differentially expressed between tumors and normal tissues. Then, used functional enrichment analysis to analyze the biological functions of the differentially expressed RBP. Used univariate Cox regression analysis to screen prognostic-related RBP and construct a prognostic model. Subsequently, Kaplan-Meier and recipient operating characteristic (ROC) curves were drawn to evaluate the model. Finally, established a nomogram. Results: This study identified 531 differentially expressed RBPs, including 325 up-regulated and 206 down-regulated RBPs, respectively. Then six independent prognostic-related RBPs (REXO2, MARS2, XPO5, YBX1, YBX2, and CELF4) were used to construct a prognostic model. According to this model, the overall survival (OS) of patients in the high-risk score group was significantly lower than that of the low-risk score group. In the training queue and the test queue, the areas under the ROC curve were 0.799 and 0.669, respectively, showing the moderate predictive value of the model. Conclusion: We have developed and validated the RBP-related prognostic model.


2021 ◽  
Vol 20 ◽  
pp. 153303382110195
Author(s):  
Ting Li ◽  
Wenjia Hui ◽  
Halina Halike ◽  
Feng Gao

Background: Colorectal cancer (CRC) is a kind of gastrointestinal tumor with serious high morbidity and mortality. Several reports have implicated the disorder of RNA-binding proteins (RBPs) in plenty of tumors, associating it to tumorigenesis and disease progression. The study is intended to construct novel prognostic biomarkers associated with CRC patients. Methods: Data of gene expression was acquired from the TCGA database, prognosis-related genes were selected. Besides, we analyzed GO and KEGG pathways. Univariate and multivariate Cox analyses were performed to generate a prognostic-related gene signature, which was evaluated by the Kaplan-Meier (K-M) and the Receiver Operating Characteristic (ROC) curve. The independent prognostic factor was established by survival analysis. GSE38832 dataset was used to validate the signature. Finally, expression of 8 genes was further confirmed by qRT-PCR in SW480 and SW620 cell lines. Results: We obtained 224 differentially expressed RBPS in total, of which 78 were downregulated and 146 were upregulated. Univariate COX analysis was conducted in the TCGA cohort to select 13 RBPs with P < 0.005, stepwise multivariate COX regression analysis was used to construct an 8—RBP signature (TERT, PPARGC1A, BRCA1, CELF4, TDRD7, LUZP4, PNLDC1, ZC3H12C). Based on the model, systematic analysis illustrated that a high risk score was obviously connected to a poor prognosis. The prognostic value of the risk score was validated in GSE38832 dataset, indicating that the risk model was accurate and effective. The prognostic signature-based risk score was identified as an independent prognostic indicator for CRC. The expression results of qRT-PCR were consistent with the results of differential expression analysis. Conclusions: The eight-RBP signature can predict the survival of CRC patients and potentially act as CRC prognostic biomarker.


2021 ◽  
Author(s):  
Zhiyuan Huang ◽  
Fang Li ◽  
Qinchuan Li

Abstract Background: It has been demonstrated by studies globally that RNA binding proteins (RBPs) took part in the development of cervical cancer (CC). Few studies concentrated on the correlation between RBPs and overall survival of CC patients. We retrieved significant DEGs (differently expressed genes, RNA binding proteins) correlated to the process of cervical cancer development. Methods: Expressions level of genes in cervical cancer and normal tissue samples were obtained from GTEx and TCGA database. Differently expressed RNA binding proteins (DEGs) were retrieved by Wilcoxon sum-rank test. ClusterProfiler package worked in R software was used to perform GO and KEGG enrichment analyses. Univariate propotional hazard cox regression and multivariate propotional hazard cox regressions were applied to identify DEGs equipped with prognostic value and other clinical independent risk factors. ROC curve was drawn for comparing the survival predict feasibility of risk score with other risk factors in CC patients. Nomogram was drawn to exhibit the prediction model and validated by C-index and calibration curve. Correlations between Differentially expressed RNA binding proteins (DEGs) and other clinical features were investigated by t test or Cruskal wallis analysis. Correlation between Immune and DEGs in cervical cancer was investigated by ssGSEA. Results: 347 differentially expressed RBPs (DEGs) were retrieved from cervical cancer tissue and normal tissue samples. GO enrichment analysis showed that these DEGs involved in RNA splicing, catabolic process and metabolism. Cox regression medel showed that there were ten DEGs significantly associated with overall survival of cervical caner patients. WDR43 (HR = 0.423, P=0.008), RBM38 (HR = 0.533, P<0.001), RNASEH2A (HR=0.474, P=0.002) and HENMT1 (HR=0.720, P=0.071) played protective roles in survival among these ten genes. Stage (Stage IV vs Stage I HR = 3.434, P<0.001) and risk score (HR = 1.214, P< 0.001) were sorted as independent prognostic risk factors based on multivariate cox regression. ROC curve validated that risk score was preferable to predict survival of CC patients than other risk factors. Additionally, we found some of these ten predictor DEGs were correlated significantly in statistic with tumor grade or stage, clinical T stage, clinical N stage, pathology or risk score (all P< 0.05). Part of immune cells and immune functions showed a lower activity in high risk group than low risk group which is distincted by median risk score. Conclusion: Our discovery showed that many RNA binding proteins involved in the progress of cervical cancer, which could probably serve as prognostic biomarkers and accelerate the discovery of treatment targets for CC patients.


2021 ◽  
Author(s):  
Wenjing GUO ◽  
Rui Chen ◽  
Hui Deng ◽  
Mengxian Zhang

Abstract Background: Glioblastoma(GBM) is a common primary malignant brain tumor with poor prognosis, and currently effective therapeutic strategies are still limited. RNA binding proteins(RBPs) dysregulation has been reported in various cancers and is closely related to tumor initiation and progression. However, little is known about the role of RBPs in GBM.Methods: We downloaded RNA-seq transcriptome from TCGA database and differently expressed RBPs were screened between tumor and normal tissues. Then we performed functional enrichment analysis of these RBPs and based on univariate and multivariate cox regression analysis, hub RBPs were identified. Furthermore, we constructed a risk model based on hub RBPs and divided patients into high- and low-risk groups based on the median risk score. To validate the model, CGGA database were conducted as a training set and then both survival analysis and ROC curve were conducted. We also developed a nomogram based on five RBPs, which made more convenient to observe each patient’s prognosis and validated the connection between patients survival and each hub RBP . Finally, we used GEPIA website to further explore the value of these hub RBPs. Results: A total 309 differently expressed RBPs were identified, including 145 downregulated and 164 upregulated RBPs. and the result indicated that they were mainly enriched in mRNA processing, RNA splicing, RNA catabolic process, RNA transport, spliceosome, ribosome and mRNA surveillance pathway. Five hub RBPs were identified and we observed that patients with high risk score were related to poor overall survival and the AUC of ROC curve was 0.752 in TCGA. The result was subsequently proved by CGGA, showing the good prediction function of the model. Then GEPIA website suggested that MRPL41, MRPL36 and FBXO17 were closely associate with OS in GBM. Conclusion: Our result may provide novel insights into pathogenesis of GBM and development of new therapeutic targets. However, further experiments in vitro and in vivo will be warranted.


2020 ◽  
Author(s):  
Xinhong Liu ◽  
Fang Tan ◽  
Xingyao Long ◽  
Ruokun Yi ◽  
Dingyi Yang ◽  
...  

Abstract Background RNA binding proteins (RBPs) play an important role in a variety of cancers. However, the role of RBPs in colorectal adenocarcinoma (COAD) has not been studied. Integrated analysis of RBPs will provide a better understanding of disease genesis and new insights into COAD treatment. Methods The gene expression data and corresponding clinical information for COAD were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate Cox regression analysis was used to screen for RBPs associated with COAD recurrence, and multivariate Cox proportional hazards regression analyses were used to identify genes that were associated with COAD recurrence. A nomogram was constructed to predict the recurrence of COAD, and a receiver operating characteristic (ROC) curve analysis was performed to determine the accuracy of the prediction models. The Human Protein Atlas database was used in prediction models to confirm the expression of key genes in COAD patients. Result A total of 177 differentially expressed RBPs was obtained, comprising 123 upregulated and 54 downregulated. GO and KEGG enrichment analysis showed that the differentially expressed RBPs were mainly related to mRNA metabolism, RNA processing and translation regulation. Seven RBP genes (TDRD6, POP1, TDRD7, PPARGC1A, LIN28B, LRRFIP2 and PNLDC1) were identified as prognosis-associated genes and were used to construct the prognostic model. Conclusion We constructed a COAD prognostic model through bioinformatics analysis, which indicated that prognostic model RBPs have a potential role in the diagnosis and prognosis of COAD. Moreover, the nomogram can effectively predict the 1-year, 3-year, and 5-year survival rate for COAD patients.


Sign in / Sign up

Export Citation Format

Share Document